Confident decisions start with high‑integrity sample data.

Trusted by multiple Top 10 pharmas, QuartzBio’s Sample Intelligence software solution ensures samples arrive at your team analysis-ready — with complete metadata, consent, and traceability.

Is fragmented sample data already affecting your research?

Translational teams at global biopharmas face challenges they didn’t create:

  • Missing sample metadata undermining dataset integrity
  • Unclear consent linkage leading to sample exclusions
  • Broken chain of custody limiting defensibility of results
  • Upstream issues discovered too late—after analysis begins

Unlike traditional LIMS or data integration tools, Sample Intelligence identifies and resolves data quality issues before they impact analysis. Every data point is complete, traceable, and validated—so your team can trust what they see and defend what they report.

How sample data integrity builds confidence upstream:

  • Every dataset is decision-ready — Metadata, identifiers, and consent links are harmonized at ingestion across every CRO, lab, and clinical system.
  • Ensure total consent and compliance confidence with 100% consent documentation visibility — linked to every sample, visible in real time, auditable on demand.
  • Catch issues before they impact results — Continuous monitoring catches missing metadata, broken traceability, and data inconsistencies before they affect analysis.
  • Defend every scientific conclusion — Complete chain of custody reconstruction for every sample, supporting regulatory submissions and publications with full confidence.

If you’re ready to fix data quality problems at their source and regain confidence in your conclusions, explore Sample Intelligence.

Case Study: Top 5 Pharma Boosts Data Quality, Doubles Trial Capacity

“With QuartzBio, we spend 85% less time on sample-related tasks.”
–Top Biopharma

Learn how a biomarker operations team at a Top 5 pharma used the Sample Intelligence Solution to address fragmented systems, manual workflows, and lack of visibility across the sample lifecycle, achieving:

  • 100% consent documentation visibility with linked sample and consent data

  • 100% detection of missing samples — zero silent losses

  • 80% less rework by catching integrity issues upstream

  • Fewer biomarker exclusions due to metadata gaps or consent issues

Restore confidence in every dataset and decision: eliminate upstream sample chaos.

Identify hidden data risks in your sample operations and see how to eliminate them in weeks—not months, with a 15-minute workflow review.

Pinpoint the biggest data quality risks in your sample operations: